If I’m analysing the spiderplot chart correctly it appears ,percentage wise ,using efti from cycle 1 opposed to cycle 5,appears to be having a more robust affect ,if that’s the case , that’s big news ,only on small patient cohort admittedly,never the less very promising
If I’m analysing the spiderplot chart correctly it appears...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.3¢ |
Change
0.018(6.14%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.5¢ | 29.0¢ | $565.0K | 1.907M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 344870 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 237922 | 27 |
View Market Depth
| Last trade - 14.18pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
